Back
Arch Capital Group Vs. Sarepta Therapeutics Industry Stock Comparison
Buy
59
ACGL
Arch Capital Group
Last Price:
100.75
Seasonality Move:
3.33%
Sell
49
SRPT
Sarepta Therapeutics
Last Price:
138.01
Seasonality Move:
14.88%
Buy
59
Arch Capital Group (ACGL)
is a Buy
Is Arch Capital Group a Buy, Sell or Hold?
- The current Arch Capital Group [ACGL] share price is $100.41. The Score for ACGL is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- ACGL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
49
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $130.50. The Score for SRPT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ACGL Stock Price Chart
What is Arch Capital Group's stock price today?
-
The Arch Capital Group share price today is $100.41
The current trend is relatively stagnant and ACGL is experiencing buying pressure, which is a positive indicator for future bullish movement.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $130.50
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
ACGL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.84 | Sell |
Relative Strength Index (14 RSI): | 47.34 | Sell |
Chaikin Money Flow: | 702963 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (97.11 - 104.19) | Sell |
Bollinger Bands (100): | (97.7 - 111.12) | Sell |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.3 | Sell |
Relative Strength Index (14 RSI): | 64.59 | Buy |
Chaikin Money Flow: | 3149400 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (111.02 - 128.88) | Buy |
Bollinger Bands (100): | (119.18 - 142.3) | Sell |
ACGL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 98.62 | Buy |
20-day SMA: | 99.32 | Buy |
50-day SMA: | 106.23 | Sell |
200-day SMA: | 99.43 | Buy |
8-day EMA: | 99.3 | Buy |
20-day EMA: | 100.5 | Sell |
50-day EMA: | 103.39 | Sell |
200-day EMA: | 98.84 | Buy |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 112.07 | Buy |
20-day SMA: | 117.27 | Buy |
50-day SMA: | 121.92 | Buy |
200-day SMA: | 129.99 | Buy |
8-day EMA: | 116.28 | Buy |
20-day EMA: | 117.14 | Buy |
50-day EMA: | 121.91 | Buy |
200-day EMA: | 125.98 | Buy |
Arch Capital Group Earnings Growth & ACGL Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.96 per share, and an increase next year of $0.11 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.87 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.76 per share.
Arch Capital Group Technical Analysis
Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |